Sort
8,912 grants matching “sars cov 2”
Add Health as a Resource for the Science of the Exposome and Risk for AD/ADRD
$1,070,406Robert A Hummer · Univ Of North Carolina Chapel Hill · U01 · FY2022 · AG
The epigenetic regulation of inflammation in tissue repair and vascular disease
$1,062,478Katherine Ann Gallagher · University Of Michigan At Ann Arbor · R35 · FY2025 · HL
The epigenetic regulation of inflammation in tissue repair and vascular disease
$1,053,460Katherine Ann Gallagher · University Of Michigan At Ann Arbor · R35 · FY2024 · HL
HIV-1 Integrase
$1,048,861Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Development Of Advanced Computer Hardware And Software
$1,048,765Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIH · FY2021 · HL
Project 1 - Coronavirus
$1,047,304Mark R Denison · University Of Alabama At Birmingham · U19 · FY2019 · AI
Lakota Center for Health Research
$1,047,242Jeffrey A Henderson · Black Hills Ctr/American Indian Health · S06 · FY2023 · GM
Vanderbilt Vaccine and Treatment Evaluation Unit - DMID 21-0012
$1,046,814Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2021 · AI
Administrative Core
$1,046,645Clifford J Rosen · Mainehealth · U54 · FY2024 · GM
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$1,046,474Amit Praful Khandhar · Hdt Bio Corporation · R61 · FY2022 · AI
Lakota Center for Health Research
$1,046,042Jeffrey A Henderson · Black Hills Ctr/American Indian Health · S06 · FY2024 · GM
Determining the Fate of Transmembrane Proteins
$1,043,590Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Development of the golden Syrian hamster model of COVID-19
$1,042,606Connie Schmaljohn · National Institute Of Allergy And Infectious Diseases · ZIG · FY2021 · AI
Understanding antibody responses and defining correlates of protection for endemic and pandemic coronavirus strains
$1,041,898Viviana A Simon · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · AI
Bioinformatics
$1,040,862Leping Li · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Understanding the short- and long-term effects of the COVID-19 pandemic on the overdose crisis
$1,038,834Magdalena Cerda · New York University School Of Medicine · R01 · FY2023 · DA
Understanding antibody responses and defining correlates of protection for endemic and pandemic coronavirus strains
$1,037,822Viviana A Simon · Icahn School Of Medicine At Mount Sinai · P01 · FY2024 · AI
Development of NHP Models for Infectious Pathogens of Man
$1,037,303Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population
$1,035,885Hillard S Kaplan · Chapman University · RF1 · FY2020 · AG
Biomarkers of Catecholaminergic Neurodegeneration
$1,033,335David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Tissue and organ specific human B cell immunity: Supplement - Metabolic Risk Factors and Inflammation in PASC Development
$1,033,284Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2022 · AI
CENTER FOR RESEARCH ON STRUCTURAL BIOLOGY OF INFECTIOUS DISEASES: SARS-CoV-2 RESEARCH
$1,032,558Peter Myler · Seattle Children'S Hospital · N01 · FY2023 · AI
Supported employment to create a community culture of SARS-CoV-2 rapid testing among people who inject drugs: PeerConnect2Test
$1,032,060Camille C Cioffi · University Of Oregon · U01 · FY2023 · DA
Project 1 - Coronavirus
$1,031,146Mark R Denison · University Of Alabama At Birmingham · U19 · FY2021 · AI
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
$1,030,000Frederick R Blattner · Dnastar, Inc. · R44 · FY2025 · AI